RIO DE JANEIRO, BRAZIL - The pharmaceutical company União Química said on Friday it has signed an agreement with the Russian Direct Investment Fund (RDIF) to produce Russia’s Sputnik V vaccine against COVID-19 starting in the second half of November.
The company said it it was bound by a confidentiality agreement not to give any technical or scientific details. The laboratory still needs to secure approval from the National Health Regulatory Agency (ANVISA) for production.
The agreement signed by União Química is the second for the production of the Russian vaccine in Brazill, where four . . .